Vancouver, BC and Houston, TX. Bio-Conscious Technologies launched Endobits Version 5, an AI-powered automated remote patient management (ARPM) platform. Endobits analyzes continuous glucose monitoring data to surface the patients who need attention first and to turn raw glucose traces into actionable hints for the care team.
"Traditional metrics, like HbA1c, are being superseded," said Amir Hayeri, Founder and CEO. "With Endobits V5, our goal is to provide a platform to do more than record the glucose levels, to continually prove value," said Dr. Jerome Fischer, Chief Medical Officer.
Get Bio-Conscious in your Google results. Add us as a preferred source and our latest research and guides surface first in Top Stories.